CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-31 | Parnell Winfred Director | Option exercise | +5,156 | 66,053 | ||
| 2025-03-31 | Parnell Winfred Director | Option exercise · Restricted Stock Units | −5,156 | 5,156 | ||
| 2025-03-31 | Beausang Ellen Director | Option exercise | +1,615 | 1,615 | ||
| 2025-03-31 | Beausang Ellen Director | Option exercise · Restricted Stock Units | −1,615 | 4,843 | ||
| 2025-03-31 | Herchuk Jannie Prestridge Director | Option exercise | +8,438 | 74,065 | ||
| 2025-03-31 | Herchuk Jannie Prestridge Director | Option exercise · Restricted Stock Units | −8,438 | 8,437 | ||
| 2025-03-31 | Fralick Celeste Rachelle Director | Option exercise | +5,000 | 55,665 | ||
| 2025-03-31 | Fralick Celeste Rachelle Director | Option exercise · Restricted Stock Units | −5,000 | 5,000 | ||
| 2025-03-31 | Cavanaugh Stefanie L. Director | Option exercise | +5,938 | 72,789 | ||
| 2025-03-31 | Cavanaugh Stefanie L. Director | Option exercise · Restricted Stock Units | −5,938 | 5,937 | ||
| 2025-03-31 | Ragard John Phillip Director | Option exercise | +4,843 | 129,890 | ||
| 2025-03-31 | Ragard John Phillip Director | Option exercise · Restricted Stock Units | −4,843 | 4,844 | ||
| 2025-03-11 | Beausang Ellen Director | Grant or award · Restricted Stock Units | −6,458 | 6,458 | ||
| 2025-03-06 | SCHULER JACK W 10% owner | Purchase · Senior Secured Convertible Note due 2030 | +0 | $200,000.00 | $0 | |
| 2025-01-08 | Milligan Sandra Interim CEO | Shares withheld for taxes | −6,356 | $0.70 | $4K | 13,644 |
| 2024-12-31 | Milligan Sandra Interim CEO | Option exercise | +20,000 | 20,000 | ||
| 2024-12-31 | Milligan Sandra Interim CEO | Option exercise · Restricted Stock Units | +20,000 | 0 | ||
| 2024-12-31 | Ragard John Phillip Director | Option exercise | +4,844 | 125,047 | ||
| 2024-12-31 | Ragard John Phillip Director | Option exercise · Restricted Stock Units | −4,844 | 9,687 | ||
| 2024-12-31 | Parnell Winfred Director | Option exercise | +5,157 | 60,897 |
Page 3 of 15 · 296 trades